Fengxia Yan

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 7

Top Topics

Atrial Fibrillation

Network Analysis

Top Venues

Journal of advanced nursing

Journal of cellular and molecular medicine

Neuropsychiatric disease and treatment

This page only lists publications with an associated author ORCID identifier.

Publications

Kebing Zhou, Xiaojiao Huang, Meiling Chen, Zhiying Li, Jieying Qin, Yelin Ji, Xuefen Yu, Fengxia Yan
Pre-hospital symptom clusters and symptom network analysis in decompensated cirrhotic patients: A cross-sectional study. Journal of advanced nursing (2024)
Kebing Zhou, Xiaojiao Huang, Meiling Chen, Zhiying Li, Jieying Qin, Yelin Ji, Xuefen Yu, Fengxia Yan
Pre-hospital symptom clusters and symptom network analysis in decompensated cirrhotic patients: A cross-sectional study. Journal of advanced nursing 80 (7) (2024)
Kebing Zhou, Xiaojiao Huang, Meiling Chen, Zhiying Li, Jieying Qin, Yelin Ji, Xuefen Yu, Fengxia Yan
Pre-hospital symptom clusters and symptom network analysis in decompensated cirrhotic patients: A cross-sectional study. Journal of advanced nursing 80 (7) (2024)
Kebing Zhou, Yu Zhou, Yuena Zeng, Jiahui Zhang, Xiaoyan Cai, Jieying Qin, Zhiying Li, Fengxia Yan
Research Hotspots and Global Trends of Transcranial Direct Current Stimulation in Stroke: A Bibliometric Analysis. Neuropsychiatric disease and treatment 19 (2023)
Kebing Zhou, Yu Zhou, Yuena Zeng, Jiahui Zhang, Xiaoyan Cai, Jieying Qin, Zhiying Li, Fengxia Yan
Research Hotspots and Global Trends of Transcranial Direct Current Stimulation in Stroke: A Bibliometric Analysis. Neuropsychiatric disease and treatment 19 (2023)
Fengxia Yan, Rifang Liao, Marta Silva, Shuai Li, Yizhou Jiang, Tangming Peng, Philip Lazarovici, Wenhua Zheng
Pristimerin-induced uveal melanoma cell death via inhibiting PI3K/Akt/FoxO3a signalling pathway. Journal of cellular and molecular medicine 24 (11) (2020)
Xiaoying Zhang, Lifang Wang, Lizhi Peng, Xiaoying Tian, Xiaoyuan Qiu, Huan Cao, Qiaohong Yang, Rifang Liao, Fengxia Yan
Dihydromyricetin protects HUVECs of oxidative damage induced by sodium nitroprusside through activating PI3K/Akt/FoxO3a signalling pathway. Journal of cellular and molecular medicine 23 (7) (2019)